OSUR — ORASURE TECHNOLOGIES INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1116463 ·
Last close
$3.51
Market Cap
$242.36M
52W High
$4.58
52W Low
$2.08
ADV30
624,706
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 30,907,000 | 13,969,000 | -12,209,000 | -13,094,000 | 349,466,000 | 148,238,000 | 42,333,000 |
| Jun 2026 | 30,639,000 | 13,317,000 | -17,153,000 | 6,249,000 | 360,552,000 | 160,582,000 | 42,775,000 |
| Mar 2026 | 27,925,000 | 11,804,000 | -23,176,000 | -22,377,000 | 379,169,000 | 176,964,000 | 65,845,000 |
| Dec 2025 | 26,763,000 | 10,968,000 | -16,852,000 | -19,286,000 | 403,168,000 | 199,278,000 | 62,341,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-43,684,000
Investing CF
$-9,418,000
Financing CF
$-13,678,000
CapEx
$-5,937,000
Dividends Paid
—
Buybacks
$-13,882,000
EPS Diluted TTM
$-0.69
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-201,384,000
Inventory
$30,420,000
Receivables
$31,817,000
ST Investments
—
EBIT TTM
$-69,390,000
Pretax Income TTM
$-45,122,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$116,234,000
EBITDA
$-58,307,000
Free Cash Flow
$-47,510,752
Enterprise Value
$113,360,104
Total Cash
$148,238,000
Total Debt
$11,647,000
Shares Out
69,047,266
Trailing EPS
$-0.69
Book Value
$4.45
ROE
-14.5%
ROA
-10.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 115,021,000 | -68,124,000 | -68,731,000 | 403,168,000 | 62,341,000 | 340,827,000 | -49,023,000 |
| Dec 2024 | 185,827,000 | -23,858,000 | -19,500,000 | 479,659,000 | 69,321,000 | 410,338,000 | 27,374,000 |
| Dec 2023 | 405,472,000 | 43,414,000 | 53,655,000 | 482,845,000 | 52,174,000 | 430,671,000 | 141,583,000 |
| Dec 2022 | 387,479,000 | -5,243,000 | -17,133,000 | 444,180,000 | 79,755,000 | 364,425,000 | -47,202,000 |
TTM Snapshot
Revenues TTM
$112,412,000
NetIncome TTM
$-49,126,000
OpCashFlow TTM
—
Assets (Latest)
$360,552,000
Forward EPS
$-0.48
Max Pain — expiry 2027-01-15
max pain strike: $2.50 · spot: $3.59 · call oi: 3,624 · put oi: 11
Expected Move to 2027-01-15:
±$1.48
(41.09%) —
implied range
$2.11 –
$5.06
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZJYL | Jin Medical International Ltd. | $248.61M | $3.38 | — |
| CLPT | ClearPoint Neuro, Inc. | $251.95M | $7.86 | — |
| PROF | Profound Medical Corp. | $259.32M | $7.08 | — |
| SSII | SS Innovations International, Inc. | $266.51M | $1.33 | — |
| OFIX | Orthofix Medical Inc. | $271.87M | $6.67 | — |
News headlines (Yahoo Finance, 1h cache)
OraSure Technologies (OSUR) Sees Activist Pressure Ease After Reaching Agreement with Altai Capital
2026-11-10 18:49 · Yahoo
OraSure (OSUR) Q3 2026 Earnings Call Transcript
2026-11-10 14:43 · Yahoo
OraSure Technologies, Inc. Q3 2026 Earnings Call Summary
2026-11-10 13:30 · Yahoo
OraSure Technologies Q3 Earnings Call Highlights
2026-11-10 01:14 · Yahoo
OraSure: Q3 Earnings Snapshot
2026-11-09 22:17 · Yahoo
OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion
2026-11-09 21:05 · Yahoo
OraSure Technologies (OSUR) Stock Fair Value Rises As Testing Funding Outlook Stabilizes
2026-11-03 14:09 · Yahoo
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
2026-10-26 20:05 · Yahoo
OraSure (OSUR) Returns To Profit, But Growth Remains Elusive
2026-09-06 11:48 · Yahoo
OraSure (OSUR) Q2 2026 Earnings Call Transcript
2026-08-13 00:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.